Market Highlights
- SomaLogic, a proteomics company that uses protein analysis to support drug development, has been acquired by Illumina Inc. for $350.0 million in cash, with an additional $75.0 million tied to future performance targets.
- DMC Biotechnologies, which uses precision fermentation to produce sustainable chemicals and food ingredients, raised $4.9 million in later-stage VC funding.
- Venture capital (VC) funding in Denver-Boulder has already surpassed the total raised in both 2023 and 2024, positioning 2025 as one of its strongest fundraising years to date.